S

Sharps Technology Inc
NASDAQ:STSS

Watchlist Manager
Sharps Technology Inc
NASDAQ:STSS
Watchlist
Price: 1.75 USD -2.23%
Market Cap: $67.7m

Sharps Technology Inc
Pre-Tax Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sharps Technology Inc
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Sharps Technology Inc
NASDAQ:STSS
Pre-Tax Income
-$270.3m
CAGR 3-Years
-288%
CAGR 5-Years
-159%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Pre-Tax Income
$227.2m
CAGR 3-Years
22%
CAGR 5-Years
13%
CAGR 10-Years
N/A
ICU Medical Inc
NASDAQ:ICUI
Pre-Tax Income
$4.4m
CAGR 3-Years
N/A
CAGR 5-Years
-46%
CAGR 10-Years
-24%
Align Technology Inc
NASDAQ:ALGN
Pre-Tax Income
$585.3m
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
12%
Lantheus Holdings Inc
NASDAQ:LNTH
Pre-Tax Income
$313.8m
CAGR 3-Years
127%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Pre-Tax Income
$170.9m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
19%
No Stocks Found

Sharps Technology Inc
Glance View

Market Cap
67.7m USD
Industry
Health Care

Sharps Technology Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Melville, New York. The company went IPO on 2022-04-14. Sharps Technology, Inc. is a medical device company that has designed and patented various safety syringes and is seeking commercialization by manufacturing and distribution of its products. The firm provides Sharps Provensa, a line of smart safety syringes that offer solutions to global healthcare crises. Its Ultra-Low Waste syringes offer a solution to minimize vaccine waste while offering reliable needlestick protection. Its features include traditional one-handed operation, reliable needlestick protection, passive and automatic safety features activated for maximum protection before withdrawal of the needle from the patient, SharpsLock interchangeable needle heads connect fast from drawing medication to injection, orange color plunger tip contrasts against black color graduation for proper reading of medication, reduces costly discarded medicine from every inefficient injection with its low-dead space syringes, no leakage, and prevents improper reuse of needles and syringes.

STSS Intrinsic Value
0.79 USD
Overvaluation 55%
Intrinsic Value
Price $1.75
S

See Also

What is Sharps Technology Inc's Pre-Tax Income?
Pre-Tax Income
-270.3m USD

Based on the financial report for Dec 31, 2025, Sharps Technology Inc's Pre-Tax Income amounts to -270.3m USD.

What is Sharps Technology Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-159%

Over the last year, the Pre-Tax Income growth was -5 074%. The average annual Pre-Tax Income growth rates for Sharps Technology Inc have been -288% over the past three years , -159% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett